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Assessment of Left Ventricular Function Pre and Post Percutanous Coronary
Intervention to Chronic Total Coronary Occlusion Doppler Tissue Imaging Study
Wassam El Din H. El Shafey
Menouﬁa University Hospital, Shebein El Kom, Egypt
BACKGROUND The rationale for the recanalization of a chronic total coronary oc-
clusion is the possible improvement of left ventricular function through the recovery
of hibernating myocardium. TDI can be used for assessment of both global and
regional LV function with high temporal and spatial resolution. Purpose: Assessment
of LV function before and after CTOPCI by PW-TDI.
METHODS The study enrolled 40 patients with CTO,37 patients succeeded to com-
plete the ﬁnal follow up ,22 patients were without infarction in the territories of
recanalized CTO vessel (group I), 15 patients with infarction in CTO territories of
recanalized CTO vessel (group II). All were subjected to conventional echo Doppler
and DTI examination.PW-DTI was used to assess velocity curves of basal and mid
segments of LV walls. The following indices were measured Tp, Sv, E’, A’, E’/A’, Acc
IVC,IVRT, IVCT, CT and TEI index.
RESULTS After recanalization of CTO vessel by PCI non infarction group of patients
showed highly signiﬁcant improvement of LVEF% after 3 months follow up (P<0.001)
while infarction group did not show any signiﬁcant improvement (P¼NS). In LAD,LCX
and RCA subgroup non infarction patients showed reduction in LVESv, increased FS%
and EF% after 3 months follow up, also there were improvement of TDI parameters in
the form of increased E’ and ACC of IVC in all 3 subgroups and increased E’/A’ in LAD
and LCX and increased in Peak velocity of IVC and reduction of A’ and time to peak of
IVC in both LAD and RCA, only S wave velocity increased in LAD subgroup after
3 months F.U.
CONCLUSION Patients with CTO, Acc. of IVC measured by PW-TDI is differentiating
early improvement after successful recanalization of CTO by PCI, Non infarction
territories might recover at earlier stage than patients with MI.
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The Impact Of Presence Of The Chronic Total Occlusion On The Prognosis Of The
Patients With Preserved Left Ventricular Function After Suffering From Acute
Myocardial Infarction
Yukio Mizuguchi, Akihiko Takahashi, Takeshi Yamada, Norimasa Taniguchi,
Shunsuke Nakajima, Tetsuya Hata
Sakurakai Takahashi Hospital, Kobe, Japan
BACKGROUND Chronic total occlusion (CTO) in the non-infarcted-related artery was
reported to worsen immediate clinical outcome in patients with acute myocardial
infarction (AMI). However, the prognosis of such patients with preserved left ven-
tricular function has not been clariﬁed yet. Our objectives were to evaluate whether
the presence of CTO solely contributes to worsen the prognosis in the patients with
well-preserved heart function after primary PCI.
METHODS We retrospectively evaluated 353 consecutive AMI patients with preserved
left ventricular pump function (left ventricular ejection fraction; LVEF 40%) who
underwent primary percutaneous coronary intervention (PCI) in our hospital between
January 2008 and December 2012. AMI patients complicated with cardiopulmonary
arrest out of the hospital (n¼33), having the left main trunk culprit lesion (n¼23), and
diagnosed after 24 hours from the symptoms onset (n¼62) were excluded from total
study population. The patients required to an extracorporeal membrane oxygenator
(ECMO) for hemodynamic support during and after PCI were excluded because LVEF
could not be evaluated accurately due to inﬂuence on hemodynamics by ECMO.
RESULTS Of those, 25 (7.0%) patients had CTO lesions in a non-infarct related artery
(CTO patients). The LVEF estimated by echocardiography after primary PCI was
similar between CTO patients and patients without CTO lesion (non CTO patients)
(55.18.6% vs 58.09.4%; p¼0.07). CTO patients were signiﬁcantly more likely to be
associated with cardiogenic shock (24.0% vs 7.6%; p<0.05) and to require intraaortic
balloon pumping (56.0% vs 12.5%; p<0.001) compared with non CTO patients. Thirty-
days mortality was signiﬁcantly higher in CTO patients as compared with non CTO
patients (12.0% vs 0.9%; p<0.001). By multivariate analysis, 30-days survival as well
as cardiogenic shock were independently associated with CTO (odds ratio [OR] 20.42,
95% CI 3.38-123.29, p<0.001, OR 3.99, 95% CI 1.46-10.92, p<0.01, respectively).
CONCLUSIONS In patients with AMI, even if their LVEF were preserved, CTO was
strongly associated with cardiogenic shock and high mortality.CRT-144
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BACKGROUND Limited data exist on the treatment of chronic total occlusions (CTO)
due to in-stent restenosis (ISR). Native coronary artery CTO is relatively rare after
stenting and it is an understudied subgroup of CTO interventions.
METHODS All patients undergoing an attempt of percutaneous coronary intervention
(PCI) due to occlusive ISR were included in our registry among 15 hospitals. CTO was
deﬁned as a coronary obstruction with TIMI ﬂow 0 with an estimated duration of
more than 3 months. A total of 233 consecutive interventions in CTOs due to ISR were
reported. Basal characteristics and angiographic features were reported. Our study
sought to evaluate PCI related success rate, procedural techniques and outcomes on
follow up among PCI-Success and PCI-Failure groups. Ischemia driven target lesion
(TLR) and target vessel (TVR) revascularization, binary restenosis, thrombosis and
MACE (TLR or TVR or CABG or all cause MI or cardiovascular death) rates were also
evaluated among both groups. Analyses were performed using the software packages
SPSS 15.0.
RESULTS Mean age was 6311 y, and 79% were men. The target lesion was located in
the right coronary artery in 47%, left anterior descending in 34,6%, circumﬂex in 18%.
Basal and angiographic features in both groups were similar. The CTO was successfully
treated in 83% of cases. Drug-eluting stents were used in 88% of cases to treat the
lesion. Procedural success was lower in circumﬂex artery when comparing with other
target vessels (86% vs. 69%%; p¼ 0.008). Coronary dissection (5,2%) and coronary
perforation without pericardial tamponade (4,5%) were more frequent complications.
The median length of the follow-up was 21,2 months and the follow-up rate was
87%. No routine angiographic follow-up was done. In the PCI-success group, ischemia
driven TLR, TVR and binary restenosis/reocclusion rates were 14.9%, 15.6% and 21,5%
respectively. Two deﬁnitive stent thrombosis, 1 probable and 2 possible were repor-
ted(ARC criteria). MACE at 12 months was 18% in PCI-Success group vs. 20,6% in PCI-
Failure group (p¼NS). Cardiac and total mortality were 2,8% vs. 7,9% (p¼0,15) and
4,5% vs. 10,5% (p¼0,23) respectively.
CONCLUSION Our registry showed success rates in ISR CTO interventions comparable
to those achieved in de novo coronary occlusions. Clinically relevant restenosis, TVR
and TLR rates remain high in our population, even taking into account that the lack of
angiographic follow-up could infra-estimate the results. There is a nonsigniﬁcant
trend towards less MACE and mortality in PCI-Success group.CLOSURE DEVICES
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Proglide Femoral Artery Closure Is Safer, More Efﬁcacious and More Cost-
effective With Greater Patient Satisfaction in Patients Who Ambulate Early
Following Diagnostic Cardiac Catheterization Compared To Manual Compression
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OBJECTIVE This was a prospective, single-center study evaluating the efﬁcacy and
cost effectiveness of early ambulation (within 30 min) following femoral artery
closure with the
ProGlideR suture-mediated vascular closure device (PD) in patients undergoing
diagnostic cardiac catheterization compared with manual compression.
BACKGROUND It is unclear whether early ambulation with ProGlide is safe and
translates into patient satisfaction and cost savings as compared with manual
compression (MC).
METHODS AND RESULTS Inclusion criteria were met in 170 patients (85 PD and 85 MC
patients). Following hemostasis, patients were ambulated 20 ft within 30 min (PD) or
after the requisite 4 h recumbent time (MC) if feasible.
The primary endpoint was time-to-ambulation (TTA) following device closure. We
also directly compared the safety of closure, times-to -hemostasis (TTH), -ambulation
(TTA) and -discharge (TTD) with MC and, using a fully allocated cost model, per-
formed cost analysis for both strategies. Multivariate analysis was used to determine
predictors of patient satisfaction. The primary endpoint of safe, early ambulation was
achieved following closure (mean of 27.114.9 min; 95% conﬁdence interval [CI]








Y25.2-30.2). Predictors of patient satisfaction in the PD group were absence of pain
during closure, decreased TTA, and drastic reductions in TTD; the latter contributed
indirectly to signiﬁcant cost-savings in the PD group (1,282.3 118.3 vs. 2,271.4 121.1
dollars, respectively; P<0.001) and incremental cost savings by strategy also favored
closure over MC ($89,124.5).
CONCLUSIONS ProGlide is safe and effective for femoral artery closure in patients
who ambulate within 30 min after cardiac catheterization; all of which translated into
improved patient satisfaction and substantial cost savings.COMPLEX CORONARY INTERVENTION
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BACKGROUND The clinical beneﬁts of paxlitaxel-coated balloon angioplasty (PCB)
have been extensively studied in bare metal stent in-stent restenosis (BMS-ISR) and in
drug eluting stent in-stent restenosis (DES-ISR). The GARO Registry is a dedicated ‘all
comers’ study in anunselected patient populationwithDES-ISR to elucidate the clinical
beneﬁts of PCB angioplasty for various types of DES-ISR in a routine clinical setting.
METHODS Under the supervision of the GARO (Groupe Angioplastie de la Région
Ouest) all data for patients treated by the PCB based on the Paccocath Technology
(SeQuent Please, B.Braun Melsungen AG) for In DES-ISR were collected in a pro-
spective data base. Quantitative analyses of the angiography of the procedure were
made by an independent core lab. The primary endpoint was clinically driven TLR at
9 months while secondary endpoints consisted of the clinically driven rates of MACE,
MI and cardiac death.
RESULTS A total of 206 patients (67.7  10.3 y, 80.6% male gender) with 210 DES-ISR
lesions were recruited in 15 French study centers. Major cardiovascular risk factors
were diabetes (41.3%), hypertension (69.4%), hypercholesterolemia (75.7%) and his-
tory of smoking (47.6%). STEMI (3.9%) and NSTEMI (13.1%) were present at baseline.
Lesion characteristics were 3.02  0.64 mm (reference vessel diameter) and 14.6 
6.5 mm (lesion length). Treated vessels were LAD (37.6%), RCA (28.6%), LCX (27.6%)
and others (6.2%). Cypher-ISR (36.7%) was the most common type of DES-ISR fol-
lowed by Taxus-ISR (20.0%), Xience-ISR (20.0%), Promus-ISR (8.1%), Endeavor-ISR
(5.7%) and others (9.5%). ISR patterns were focal (52.9%) and diffuse (47.1%). 9-month
follow-up was available in 90.8% (187/206) of all patients. The duration between DES
implantation and restenosis was 3.0  2.4 years.
The 9-month TLR rate was 7.0% (13/187) whereas incidences of MI and cardiac
death were 4.3% (8/187) and 2.1% (4/187) respectively. The composite MACE rate at 9
months was 10.2% (19/187).
CONCLUSIONS Up to date this is the largest prospective registry in an unselected
patient population with DES-ISR treated with PCB angioplasty. The rates for TLR and
MACE were low and seem to be an attractive alternative treatment option despite the
lack of reimbursement in France.
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The Efﬁcacy and Clinical Outcome of Rotational Atherectomy with Second
Generation Drug-Eluting Stents
Koshi Matsuo, Yasunori Ueda
Osaka Police Hospital, Osaka, Japan
BACKGROUND Treatment of calciﬁed lesions with balloon angioplasty has been
associated with a low success rate and high procedural complications. Rotational
atherectomy (RA) improved acute results, but a high restenosis rate remained a
problem. Therefore, the purpose of this study was to evaluate the clinical and
angiographic outcome of patients with complex and calciﬁed lesions treated with a
combination of RA and second-generation drug-eluting stent (DES) implantation.
METHODS Consecutive 55 patients received combination therapy of RA and second-
generation DES implantation at de novo lesion of native coronary artery with severe
calciﬁcation between June 2009 and December 2012. Zotarolimus-eluting stents
(ZES), biolimus-eluting stent (BES), and everolimus-eluting stents (EES) were used in
14, 7, and 34 patients, respectively. 39 patients (ZES, BES, and EES were used in 12, 6,
21 patients) received one-year follow-up angiography. The clinical and angiographic
outcome was compared among those 3 groups of different DES.
RESULTS Only one patient was dead (a cause was unknown). Target lesion revascu-
larization (TLR) rate was 0% among 3 groups. The late loss was larger in ZES than in
BES or EES (ZES vs. BES vs. EES: 0.370.20mm vs. 0.200.10mm vs. 0.160.15mm,
p<0.05).CONCLUSION The clinical outcome of 3 second-generation DES used in combination
with RA was very good, although the culprit lesions were complex with severe
calciﬁcation. Combination therapy of RA and second-generation DES appeared ac-
ceptable.
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INTRODUCTION Implantation of stiff permanent metallic implants alters blood
rheology especially at the inﬂow and outﬂow edge of the stents probably contributing
to early and late stent failure. Short Polymeric Bioresorbable vascular scaffolds (BVS)
have shown to have less impact on the natural curvature of the stent vessel compared
to Metal platform stents (MPS). The impact of long BVS on vessel curvature is
unknown.
OBJECTIVES The aim of this study was to determine if there are any signiﬁcant dif-
ferences in terms of curvature of the treated vessel after the deployment of either a
metallic stent or a polymeric scaffold device in long lesions.
METHODS This retrospective study compares 32 patients who received an MPS
(Xience, Abbott Vascular, Santa Clara, CA, US) with 32 patients treated with the ever-
olimus-eluting bioresorbable vascular scaffold (BVS-Absorb, Abbott Vascular, Santa
Clara, California). All patients received 1 BVS Absorb or MPS with a length of 28mm
deployed singly in long coronary lesions. The primary end point measured was the
relative region curvature (%) evaluated with dedicated software by angiography.
RESULTS There were 22 (68.8%) males in each group. There was no difference in
median age [BVS vs MPS: 59.6 yrs vs 64.9 yrs, p¼0.453)]. There was a signiﬁcant
difference in clinical presentation of ACS/STEMI (BVS vs MPS: 68.8% vs 40.6%, p¼
0.024). The left anterior descending artery was the most treated vessel in both groups
(BVS vs MPS: 46.9% vs 40.6%, p¼ 0.857). Pretreatment length was 22.19 mm vs
20.38 mm in the BVS and MPS groups respectively (p¼0.803). There was no signiﬁ-
cant differences in reference vessel diameter, minimal lumen diameter and per-
centage diameter stenosis in both groups. Pretreatment Diastolic curvature (DC) was
greater in the BVS group compared with the MPS group (0.305 cm-1 vs 0.257 cm-1, p¼
0.803). There was a signiﬁcant decrease in median DC in the MPS group post-treat-
ment than pre-treatment (from 0.257 cm-1 to 0.199 cm-1, p¼ 0.001). There was a
decrease in median DC in the BVS group post-treatment which trends towards sig-
niﬁcance (from 0.305 cm-1 to 0.283 cm-1, p¼ 0.056). Median Percentage relative
change in DC was signiﬁcantly lower in the BVS group compared with the MPS group
(BVS vs MPS: 7.48% vs 29.4%, p¼ 0.024). By univariate analysis, device use was an
independent predictor of change in curvature (p ¼ 0.022).
CONCLUSIONS In the deployment of long coronary scaffolds/ stents (28mm in
length), bioresorbable vascular scaffolds provides better conformability compared
with MPS.
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Role of Plaque Characterization By 64-slice Multi Detector Computed
Tomography in Prediction of Complexity of Percutaneous Coronary
Interventions
Sherif W. Ayad, Mohamed A. Sobhy, Eman M. El-Sharkawy, Mahmoud S. Abd-Elhamid
Faculty of Medicine, Alexandria, Egypt
BACKGROUND Percutaneous coronary intervention (PCI) nowadays has become
standard of care in symptomatic coronary artery disease (CAD. Lesion localization,
severe calciﬁcations, and vessel tortuosity may challenge the skills of the operator
and increase the risk of procedural complications. Coronary computed tomography
angiography (CCTA) has become a promising non-invasive imaging technique, pre-
procedural lesion characterization by CCTA might contribute to predict PCI
complexity in extensive and complex CAD.
AIM To determine the predictive value of coronary plaque characterization as
detected by 64- slice multi-detector Computed tomography(MDCT) in prediction of
the procedural complexity of elective percutaneous coronary non CTO intervention.
PATIENTS Retrospective study involving 45 patients in whom PCIs were performed for
60 single coronary lesions within 6 months of pre-procedural CCTA at ICC hospital.
METHODS All patients had MDCT coronary angiography The CT derived parameters
included inour studywas: calciumscoring,plaqueanatomy (site, sidebranch involvement,
degree of stenosis, morphological type), plaque length, volume, density and area.
RESULTS Median Agatston score was signiﬁcantly higher in lesions with complex as
compared to those with non-complex interventions with a mean of 266.51 155.93vs
168.76  70.53 with the P value ¼ 0.034. Regarding plaque density, Hounsﬁeld Units
were higher in lesions with complex as compared to non-complex PCI (371.85 (48.0 to
